United to change the trajectory of lung cancer
At Johnson & Johnson, we collaborate across our Pharmaceutical and MedTech teams and with strategic partners to unleash the full potential of lung cancer science to help change the trajectory of this complex disease.
-
-
“Our goal is to prevent lung cancer from happening in the first place”
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer. -
Lung cancer requires a multidisciplinary approach
